000 01433 a2200409 4500
005 20250513174850.0
264 0 _c19990528
008 199905s 0 0 eng d
022 _a0269-9370
024 7 _a10.1097/00002030-199902040-00005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFoudraine, N A
245 0 0 _aImmunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients.
_h[electronic resource]
260 _bAIDS (London, England)
_cFeb 1999
300 _a177-84 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAIDS-Related Opportunistic Infections
_xdrug therapy
650 0 4 _aAdult
650 0 4 _aAnti-HIV Agents
_xtherapeutic use
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHIV-1
_ximmunology
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMycobacterium Infections, Nontuberculous
_xdrug therapy
650 0 4 _aMycobacterium avium-intracellulare Infection
_xdrug therapy
650 0 4 _aMycobacterium xenopi
_ximmunology
700 1 _aHovenkamp, E
700 1 _aNotermans, D W
700 1 _aMeenhorst, P L
700 1 _aKlein, M R
700 1 _aLange, J M
700 1 _aMiedema, F
700 1 _aReiss, P
773 0 _tAIDS (London, England)
_gvol. 13
_gno. 2
_gp. 177-84
856 4 0 _uhttps://doi.org/10.1097/00002030-199902040-00005
_zAvailable from publisher's website
999 _c10162194
_d10162194